Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease
- Scott M. Palmer(corresponding author),
- Lisa J. Robinson,
- Andrew Wang,
- James R. Gossage,
- Thomas Bashore,
- Victor F. Tapson
- Duke University
Abstract
Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension associated with fibrotic occlusion of the smaller pulmonary veins. Although vasodilator therapy is effective in many patients with primary pulmonary hypertension, the role of vasodilators in PVOD is unclear because of concerns about precipitating pulmonary edema. Recently, however, there have been reports of successful therapy with oral vasodilators or intravenous administration of prostacyclin in patients with PVOD. In contrast, a patient with PVOD is described who developed acute pulmonary edema and respiratory failure during low-dose prostacyclin infusion, leading to death. This report suggests that vasodilators, especially prostacyclin, must be used with extreme caution in patients with known PVOD.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 237-240 (4 pages)Journal (Volume, Issue Number)
CHEST (Volume 113, Issue 1)Publication milestones
- Published - 1998
Publication status
ISSN
0012-3692Publication IDs
- Scopus: 0031983972
- PubMed: 9440597
